Bausch Health (BHC) Companies announced the commercial expansion of OraPharma into Canada and Puerto Rico. This strategic move reflects OraPharma’s commitment to improving oral health awareness, providing access to treatments within periodontal disease management, and strengthening partnerships with local distributors and dental professionals in these markets.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Closing Bell Movers: Meta sinks, Alphabet jumps after earnings
- Bausch Health reports Q3 revenue $2.68B, consensus $2.63B
- Bausch Health sees FY25 revenue $10.05B-$10.25B, consensus $10.12B
- Bausch Health options imply 8.2% move in share price post-earnings
- Midday Fly By: Nvidia hits $5T market cap, Boeing takes big 777X charge